OPRK1 and migraine disorder: Interestingly, the kappa opioid receptor antagonist norbinaltorphimine (nor-BNI) given before stress exposure prevented the deleterious effect of stress on migraine susceptibility, suggesting the kappa receptor as a pharmacological target for the prevention of migraine triggered by stress [138].